Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z-338 Phase IIb study in functional dyspepsia
2005-005621-55Phase 2Completed
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acotiamide in functional dyspepsia (FD) (3 arms), sponsored by Zeria Pharmaceutical Co., Ltd. Primary endpoint: Proportion of responders to the Global Subject Outcome Assessment. Started Jan 2006; status: completed.
02
Drugs
acotiamide
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on 2005-005621-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005621-55.